Narrative Edge

DT

USD 43.70 -5.12% · 1Y
Latest: bear
Price
Oct 30 Nov 2 Nov 3 Nov 4 Nov 5 57.70 54.20 50.70 47.20 43.70
Oct 6 Oct 14 Oct 21 Oct 28 Nov 5 65.25 59.86 54.48 49.09 43.70
Aug 6 Aug 28 Sep 22 Oct 14 Nov 5 $65 $71 65.25 59.86 54.48 49.09 43.70
May 6 Jun 23 Aug 7 Sep 22 Nov 5 $50 $65 $71 65.25 57.62 49.99 42.36 34.73
Nov 6 Feb 6 May 8 Aug 10 Nov 5 $50 $65 $71 65.25 57.03 48.81 40.58 32.36
Nov 4 May 5 Nov 3 May 11 Nov 5 $50 $65 $71 64.05 56.13 48.21 40.28 32.36
Nov 6 Aug 5 May 5 Feb 9 Nov 5 $50 $65 $71 64.05 56.13 48.21 40.28 32.36
Full synthesis

Viewpoint Synthesis

Bull Thesis

DT can reaccelerate as a larger renewal base, rising usage, and AI observability broaden growth; discounted valuation offers rerating potential.

1. Renewals and consumption create a near-term growth bridge

  • A renewal pool roughly 50% larger, weighted to the second half, could lift ARR growth. ↴
  • Usage above 20% indicates demand beneath reported growth is stronger than headline ARR suggests. ↴
  • Logs could contribute roughly half of incremental ARR, diversifying growth beyond renewals. ↴

2. AI observability expands the product opportunity

  • AI workloads already grow faster within DT’s customer base, turning adoption into measurable expansion potential. ↴
  • Arize accelerates the AI observability roadmap, lowering development risk while broadening telemetry coverage. ↴
  • AI observability could contribute three to four growth points, expanding the addressable spending pool. ↴

3. Growth upside is not fully reflected in valuation

  • A discount to Datadog leaves room for multiple recovery if ARR momentum improves. ↴
  • Cross-selling Arize into DT’s installed base creates incremental revenue rather than relying solely on share gains. ↴
  • Expanding margins could support a higher free-cash-flow multiple, amplifying earnings growth in valuation. ↴
Bear Thesis

The reacceleration case depends on renewals converting into ARR; recent weakness and softer subscription signals leave estimates vulnerable.

1. Recent growth execution raises estimate risk

  • Net-new ARR growth missed expectations and decelerated, weakening confidence in the growth baseline. ↴
  • Weaker net-new ARR and below-consensus subscription guidance pressured the outlook despite an in-line annual view. ↴
  • Below-Street subscription guidance raises risk that reported growth lags renewal expectations. ↴

2. Renewal-led acceleration is back-half weighted

  • With most renewal dollars landing in the second half, delayed conversion could push the ARR inflection out. ↴
  • Management’s conservatism around DPS renewals leaves a key growth catalyst less certain. ↴

3. The stock remains exposed to sharp reactions on execution

  • A sharp post-print decline shows that ARR delivery can overwhelm longer-term platform optimism. ↴
Opinion timeline

Opinion Timeline

Bull Plane
TIME
Bear Plane
No bull argument in this report.
2026-11-03

DT -13% on a 2Q ARR Deel and SHOP -15% on a messy print with lower GMV, better rev guide, but worse opex guide. We sent out first takes on both here.

2026-11-03 Back to thesis

The stock declined due to a miss on Net New Annual Recurring Revenue (NNARR), slipping Net Retention Rate (NRR), and a full-year ARR guide that only included Arize, with management attributing weakness to slipping expansions rather than renewals.

2026-11-03 Back to thesis

Agent proliferation is expected to expand observability demand, with the company's consumption already growing over 20%.

2026-10-12 Back to thesis

FY27 renewals are expected to help Annual Recurring Revenue (ARR) catch up, with DPS ARR up for renewal significantly higher year-over-year and a large portion landing in 2H, setting up a F2H27 inflection.

2026-10-12 Back to thesis

Arize adds upside through approximately 200 enterprise customers and over 4K monthly Phoenix users.

2026-10-12 Back to thesis
2026-10-12
No bear argument in this report.

AI observability is expected to significantly contribute to total observability spend, potentially adding to the company's growth and supporting high-teens ARR growth.

2026-10-01 Back to thesis

There is significant upside from cross-selling into the company's installed base, and the opportunity appears largely incremental rather than share-shifting.

2026-10-01 Back to thesis

UBS sees ~$40–50M of Arize net-new ARR in FY28, with the bigger upside from cross-selling into DT’s installed base; DDOG should also benefit as the opportunity looks largely incremental rather than share-shifting.

2026-10-01 Back to thesis

UBS checks with Arize customers suggest that AI observability could account for a significant portion of overall observability spending, contributing to growth.

2026-10-01 Back to thesis
2026-10-01
No bear argument in this report.

The company's AI positioning is showing tangible traction, with over 1,000 customers observing AI/LLM workloads, an increase of 150 quarter-over-quarter, and AI cohorts growing approximately 1.5 times faster than non-AI customers.

2026-09-24 Back to thesis

The Arize acquisition adds approximately 200 basis points to ARR growth and strengthens the company's AI-observability platform, while logs consumption has doubled to approximately $200 million annualized in two quarters, and upcoming DPS renewals should support NRR acceleration.

2026-09-24 Back to thesis

The analyst sees a path back to over 20% revenue growth.

PT $71 from $60
2026-09-24 Back to thesis
2026-09-24
No bear argument in this report.

Go-to-market execution is improving into an FY27 renewal base that is up significantly year-over-year, with Logs, strategic accounts, and AI monetization offering incremental upside not fully reflected in guidance.

2026-09-15 Back to thesis

Arize is expected to accelerate Dynatrace's AI observability roadmap by approximately 18 months, and FY27 NNARR could exceed $370M, representing strong year-over-year growth, while organic growth remains robust.

2026-09-15 Back to thesis

Dynatrace trades at a significant discount to Datadog despite improving ARR momentum and potential Investor Day catalysts.

2026-09-15 Back to thesis

Citi says GTM execution is improving into an FY27 renewal base up ~50% y/y, with Logs, strategic accounts and AI monetization still offering incremental upside largely absent from guidance. Citi sees Arize accelerating DT’s AI observability roadmap by ~18 m...

2026-09-15 Back to thesis
2026-09-15
No bear argument in this report.

The company is expected to reaccelerate in the observability market, driven by a significantly larger FY27 renewal cohort and underlying usage growth exceeding 20%.

2026-08-25 Back to thesis

Net-new ARR and total ARR are projected to return above 20% growth, with platform expansion across logs, AI, and autonomous operations contributing to increased wallet share.

2026-08-25 Back to thesis

Expanding margins are expected to lead to a rerating of the stock from approximately 20x to 27x CY27 FCF.

2026-08-25 Back to thesis

MS upgraded the stock, believing it is next in line to reaccelerate in a healthier observability market.

2026-08-25 Back to thesis

The FY27 renewal cohort is approximately 50% larger than FY26 and about 70% weighted to 2H, indicating strong future revenue potential.

2026-08-25 Back to thesis

Underlying usage is already growing over 20%.

2026-08-25 Back to thesis

MS believes this can push net-new ARR and total ARR back above 20% growth.

2026-08-25 Back to thesis

Platform expansion across logs, AI, and autonomous operations is expected to add wallet-share upside.

2026-08-25 Back to thesis

DT +2% as MS upgraded saying they are next in line to reaccelerate in a much healthier observability market, with a FY27 renewal cohort ~50% larger than FY26 and ~70% weighted to 2H, while underlying usage is already growing >20%.

2026-08-25 Back to thesis
2026-08-25
No bear argument in this report.

The recent underperformance and acquisition of Arize AI create a better risk/reward setup.

PT $65
2026-08-18 Back to thesis

The Arize acquisition is expected to accelerate the company's "observability for AI" roadmap and broaden telemetry across AI application development.

2026-08-18 Back to thesis

The stock currently trades at a meaningful discount compared to DDOG and historical levels.

2026-08-18 Back to thesis

Near-term catalysts include an upcoming investor day, activist involvement, broader software M&A interest, and potential buyback optionality following a capital raise.

2026-08-18 Back to thesis
2026-08-18

Citi reiterates Buy, raises its PT to $65 and adds a 90-day positive Catalyst Watch, arguing DT’s recent underperformance and Arize AI acquisition create a better risk/reward setup. Citi sees Arize accelerating Dynatrace’s “observability for AI” roadmap and...

PT $65
2026-08-18 Back to thesis

DDOG/DT: BTIG Field Checks Show AI Driving Strong Observability Demand

2026-07-28 Back to thesis
2026-07-28
No bear argument in this report.

Hyperscaler AI capex should continue expanding, supporting "token path" winners.

2026-07-07 Back to thesis
2026-07-07
No bear argument in this report.

The company announced an Investor Day to outline its path to the "Rule of 50" in FY'29 and reiterated its intention to continue returning significant capital to shareholders under its $1 billion share repurchase authorization.

2026-07-01 Back to thesis
2026-07-01
No bear argument in this report.

Key investor concerns regarding FY27 guidance have largely been addressed, with management indicating multiple paths to achieving targets and a healthy spending backdrop for AI-native observability companies.

2026-06-18 Back to thesis

Growing traction in AI workloads, observability consolidation, and Dynatrace’s AI-driven platform support a more constructive setup into FY27.

2026-06-18 Back to thesis
2026-06-18
No bear argument in this report.

Stifel is constructive on DT’s FY27 outlook, highlighting consumption growth above 20%, accelerating log volumes, and improving sales productivity.

2026-06-16 Back to thesis

Management noted strong DPS consumption and expects ongoing log growth to contribute roughly half of FY27 incremental NNARR, supported by newer logos and a larger sales force.

2026-06-16 Back to thesis

Stifel pointed to Dynatrace’s positioning around agentic AI, arguing enterprises will need observability and automation tools to deploy AI at scale.

2026-06-16 Back to thesis

Despite some conservatism around DPS renewals, underlying business trends remain supportive of the company’s FY27 growth acceleration targets.

2026-06-16 Back to thesis

Stiefel's positive outlook, following meetings with investor relations, indicated strong DPS consumption and expectations for log growth to contribute significantly to future incremental NNARR, supported by new logos and an expanded sales force.

2026-06-16 Back to thesis
2026-06-16
No bear argument in this report.

BofA is more constructive on DT following management meetings, citing stronger revenue visibility, a larger strategic pipeline, and growing confidence in management’s execution.

2026-06-15 Back to thesis

The firm believes improving customer relationships, higher usage trends, and upcoming DPS renewals support a more predictable growth profile and stronger net-new ARR.

2026-06-15 Back to thesis

BofA sees AI and observability consolidation creating share gain opportunities for Dynatrace and raised its price target to $50 from $48.

PT $50 from $48 PT $50 from $48. B
2026-06-15 Back to thesis
2026-06-15
No bear argument in this report.

The full-year ARR guidance was healthy and stable.

2026-05-13 Back to thesis
2026-05-13

Net new ARR missed expectations and decelerated from prior quarters.

2026-05-13 Back to thesis

The first-quarter subscription revenue guidance was below Street expectations.

2026-05-13 Back to thesis

DT -8%: Q4/FY27 Guide Largely Inline; FY ARR guide In Line but weaker Q4 NN ARR # and Q1 subs hitting stock

2026-05-13 Back to thesis

Shares rose over 6% on reports that Starboard Value LP took a stake and is pushing the company to better capitalize on the shift to artificial intelligence.

2026-04-28 Back to thesis

Starboard, now a top-five shareholder, has been privately engaging with management, advocating for the board to be open to all paths to maximize shareholder value.

2026-04-28 Back to thesis
2026-04-28
No bear argument in this report.

The company is best positioned given a new logs product cycle, DPS transition resetting growth into next year, and strong margin profile (~25% FCFM) at an attractive valuation (~14x EV/FCF).

2026-04-21 Back to thesis

DT/ESTC: GS Initiates DT at Buy ($45), ESTC at Neutral ($50); AI Driving Observability Platform Shift

2026-04-21 Back to thesis

Goldman Sachs initiates DT at Buy and ESTC at Neutral, citing a structural shift in observability as AI increases data complexity, compute intensity, and demand for platforms that compress “signal-to-action.

2026-04-21 Back to thesis
2026-04-21
No bear argument in this report.

The company delivered a clean beat and raise, indicating strong performance.

2026-02-09 Back to thesis
2026-02-09
No bear argument in this report.
Sources and method

Research through 2026-11-03 · 2026-01-21 to 2026-11-03 · 18 source reports.

Price through 2026-11-05 · USD
Price cutoff for each chart range
RangePrices through
1W
1M
3M
6M
1Y
2Y
3Y
AI synthesis retained; routine evidence pending weekly review. Synthesis as of 2026-11-04; evidence available through 2026-11-03. New routine evidence is waiting for the weekly review gate (eligible after 2026-11-11). Verified source bindings; generated 2026-11-04, analyzed evidence through 2026-11-03.
Research coverage and method

Research through 2026-11-03. Artifact validity does not establish factual accuracy or research freshness.

Technical diagnostics
Research source: 2026-11-03 Processed through: 2026-11-03 Generated: 2026-11-05T21:55:38+00:00 · 0d ago Generation SHA: aedfe3ef5807 Service SHA: 50f2a97952e8